Antistreptococcal interventions for guttate and chronic plaque psoriasis

Dupire, Gwendy; Droitcourt, Catherine; Hughes, Carolyn; Cléach, L. Le

doi:10.1002/14651858.cd011571.pub2

Cited by 29 publications

(24 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…About a third of guttate psoriasis-affected individuals would progress to plaque psoriasis. [20] Furthermore, Pustular psoriasis is a rare form and has serious life-threatening complications including skeletal and joint disease seen in the generalized type of pustular psoriasis. There are salient systemic manifestations of the generalized form of pustular psoriasis, including fever, pain, and malaise.…”

Section: Reviewmentioning

confidence: 99%

A review on updates in management and Treatment of Psoriasis

Alhammad¹,

Aseri²,

Alqahtani³

et al. 2021

Arch Pharma Pract

View full text Add to dashboard Cite

Introduction: Introduction: Psoriasis is a rather common inflammatory skin disease that is characterized by the appearance of red scaly plaques and may affect any part of the body. There are certain factors that make psoriasis a challenge for physicians, these include: high prevalence, disability, chronicity, disfiguration, and associated comorbidities. The approach to the management of Psoriatic patients should also take into account the dermatological clinical features. This review would discuss and focus on recent updates in the management of Psoriatic patients and its common related issues as well as the clinical picture of psoriasis in order to understand and inform medical practitioners and develop their knowledge of the etiology of the condition, immune and environmental factors, has led to the development of precision-targeted therapies that alleviate patient morbidity. Methodology: PubMed database was searched and screened for relevant observational studies, systematic reviews, randomized controlled trials, meta-journal articles, and journal articles containing the term used in the mesh "Psoriasis", "Management" "Treatment trials" within the title or abstract. Conclusion: The physician should adhere to updated evidence-based guidelines in the management of psoriatic patients. New biologic modalities and alternative nature-based treatments for psoriasis should be studied. Pharmacodynamics profiles, administration modality, and dosing regimens for the currently available IL-17 and IL-23 inhibitors must be reexamined to improve the overall continuity of care of psoriasis patients.

show abstract

Section: Reviewmentioning

confidence: 99%

A review on updates in management and Treatment of Psoriasis

Alhammad¹,

Aseri²,

Alqahtani³

et al. 2021

Arch Pharma Pract

View full text Add to dashboard Cite

show abstract

“…First-line therapy includes topical treatments (corticosteroids, vitamin D and its analogues, retinoids, tar) (Dubertret 1992;Highton 1995;Samarasekera 2013;Weinstein 1997;. For guttate psoriasis, antistreptococcal interventions (oral antibiotics or tonsillectomy) are also prescribed; however, they are out the scope of this review as they are already covered in another review (Dupire 2019;Hone 1996;Rachakonda 2015).…”

Section: Description Of the Interventionmentioning

confidence: 99%

“…A separate systematic review addressed antistreptococcal therapeutic strategies for guttate and chronic plaque psoriasis Cochrane Database of Systematic Reviews . An update of that review has been published (Dupire 2019).…”

Section: Why It Is Important To Do This Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis

Maruani

Samimi

Stembridge

et al. 2019

Cochrane Database of Systematic Reviews

Self Cite

View full text Add to dashboard Cite

show abstract

“…2 Antibiotic therapy is routinely indicated in the setting of active streptococcal infection, however data on its value in resulting GP alone is limited, heterogeneous and conflicting. 3 This study sought to determine whether single-course oral antibiotic therapy affects time to skin clearance in acute post-active phase streptococcal guttate psoriasis.…”

Section: Introductionmentioning

confidence: 99%

Does Antibiotic Therapy Affect Time to Clearance in Post-Active Phase Streptococcal Guttate Psoriasis—A Case Control Study

Farrell¹,

Stewart

Rosén

2020

Journal of Psoriasis and Psoriatic Arthritis

View full text Add to dashboard Cite

Background: The extent of the role of streptococcal infection in the pathogenesis of guttate psoriasis is still unclear. Data on the efficacy of antibiotic therapy in guttate psoriasis is limited, heterogeneous and conflicting. Objective: We sought to ascertain whether single-course oral antibiotic therapy affects time to skin clearance in acute post-active phase streptococcal guttate psoriasis. Methods: We performed a 5-year case-control study of ASOT-positive guttate psoriasis treated with or without single-course oral antibiotic therapy with 8-week follow-up. Results: There was no significant difference between cases and controls for time to clearance (χ2 = 0.92, p = 0.82). Conclusion: Our findings suggest that single-course oral antibiotic therapy may not provide any adjunctive therapeutic benefit in the treatment of acute post-active phase streptococcal guttate psoriasis.

show abstract

Antistreptococcal interventions for guttate and chronic plaque psoriasis

Abstract: Antistreptococcal interventions for guttate and chronic plaque psoriasis.

Cited by 29 publications

References 65 publications

A review on updates in management and Treatment of Psoriasis

A review on updates in management and Treatment of Psoriasis

Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis

Does Antibiotic Therapy Affect Time to Clearance in Post-Active Phase Streptococcal Guttate Psoriasis—A Case Control Study

Contact Info

Product

Resources

About